Addressing limitations in manufacturing nucleic acid therapeutics

Funders: Medical Research Council (MRC), Engineering and Physical Sciences Research Council (EPSRC), Biotechnology and Biological Sciences Research Council (BBSRC), Innovate UK, UK Research and Innovation

Funding to set up a research consortium addressing challenges in the manufacture of nucleic acid therapeutics.

Current manufacture challenges include but are not limited to:

• scale of production
• product purity, stereochemistry and reproducibility
• sustainable production
• novel chemistries
• synthesis efficiency
• analytical oligonucleotide characterisation.

The consortium can include academic and industrial organisations in the UK and abroad. The lead organisation must be UK-based.

Consortium proposals should demonstrate how the research outputs could benefit the wider UK research and manufacturing community.

You are encouraged to explore opportunities to collaborate with the Nucleic Acid Therapy Accelerator (NATA) Hub, a new research centre in the UK.

Further details can be found here

https://www.ukri.org/opportunity/addressing-limitations-in-manufacturing-nucleic-acid-therapeutics/

Smaller awards of up to £10,000, are available to access bespoke external expertise and advice on the potential of the idea or technology and overcome well-defined barriers, for example engaging end-users and networks, commissioning market research analyses and exploring routes to market to progress their research along the translational pipeline.

Join our workshops sharing experiences of translating research into improvements in human health and learn about future funding opportunities.